WuXi Biologics is trading at HK$48.14 (+4.29%) now as healthcare-sector rotation lifts sentiment.
- Morningstar reported gains of more than 15% since the end of July, consistent with sustained sector interest rather than a fresh company-specific catalyst
- The August 14 Bestchrom divestment announcement was updated August 17
- Available coverage does not directly link it to the August 18 move